Moderna, Inc., reported Monday that its experimental COVID-1984 coronavirus vaccine had proven 94.5% effective in clinical trials, they say it's 'good news', will you be taking a jab? Can the implantable digital Immunity Passport from ID2020 be far behind?
The COVID-1984 coronavirus vaccine is nearly ready to rollout to the America people, they are touting it as "95% effective" in clinical trials, an interesting statistic to say the least. The flu shot has been around in one form or another since the late 1930's, last year nearly 52,000 people in America died of the flu. If that's the best they can do after practicing for 80 years, how well do you think a coronavirus shot rushed out in 6 months will do?
"Behold ye among the heathen, and regard, and wonder marvellously: for I will work a work in your days, which ye will not believe, though it be told you." Habakkuk 1:5 (KJB)
In the early stages of my web and graphic design career, I worked for some of our nation's top pharmaceutical companies, and I can tell you from experience of sitting in product development meetings that the "bottom line" in Big Pharma is the bottom line, and don't let anyone tell you different. Nothing is happening in 2020 that will change that, so please heed and accept my friendly word of warning concerning the Moderna vaccine.
Moderna’s messenger RNA vaccine, on the other hand, is completely new and revolutionary to say the least. It uses a sequence of genetic RNA material produced in a lab that, when injected into your body, must invade your cells and hijack your cells’ protein-making machinery called ribosomes to produce the viral components that subsequently train your immune system to fight the virus. In this case, Moderna’s mRNA-1273 is programmed to make your cells produce the coronavirus’ infamous spike protein that gives the virus its crown-like appearance (“corona” is crown in Latin) for which it is named. READ MORE
Not only is this COVID-1984 coronavirus vaccine being rushed through, this vaccine is what they call an messenger RNA vaccine, a type of vaccine that has never been approved in clinical trials ever. Think about that. Forget for a moment about a vaccine possibly being connected with the biblical Mark of the Beast, forget for a moment about human implantable digital microchips from ID2020, you are literally taking your life in your hands with Moderna's mRNA COVID-1984 vaccine.
Oh, one last thing, have you noticed how quiet Bill Gates has been lately? All this talk about vaccines being nearly ready and it's like he has fallen off the map. He's not hiding, he's waiting in the wings and preparing. Ready or not, it's almost here. I'll leave this out there for someone who needs to see it, maybe that someone is you.
SHOCK AS IT’S REVEALED AN ENZYME CALLED LUCIFERASE IS WHAT MAKES BILL GATES IMPLANTABLE QUANTUM DOT MICRONEEDLE VACCINE DELIVERY SYSTEM WORK
Moderna’s Coronavirus Vaccine 95% Effective in Clinical Trial
FROM BREITBART NEWS: The news came exactly one week after Pfizer and German pharmaceutical company BioNTech said that their coronavirus vaccine had proven 90% effective, which was heralded as an unexpected bit of good news that sent stock markets soaring.
National Public Radio reported:
The results for both vaccines come from interim analyses of large clinical studies. In the Moderna study there were 30,000 volunteers. Half got two doses of the vaccine 28 days apart, half got two shots of a placebo on the same schedule.
…
Both the Moderna and Pfizer vaccines use the same technology to make their vaccines. It’s based on a molecule known as mRNA, or messenger RNA. That molecule contains genetic instructions for making proteins inside cells.
The federal Operation Warp Speed project to hasten development of COVID-19 vaccines awarded Moderna a $1.5 billion contract in August to ramp up manufacturing and deliver 100 million vaccine doses, enough for 50 million people. The government has an option to buy up to 400 million more doses.
Moderna said Monday that it expects to be able to ship about 20 million vaccine doses in the U.S. by the end of 2020. Next year, the company said it expects to be able to make 500 million to 1 billion doses worldwide.
The Wall Street Journal noted that 95 participants in the study contracted coronavirus. Of those, only five had also received the vaccine; the other 90 had received the placebo. The Journal added: The vaccine also showed signs of being safe, though researchers and regulators must wait for more-complete safety data from the study, expected later in November.”
President Trump and Dr. Moncef Slaoui, who leads Operation Warp Speed, hinted last week in a press briefing in the Rose Garden that Moderna would announce good news. “I would expect that shortly — probably next week — we may hear what I hope to be another very good information regarding an efficacious vaccine,” Dr. Slaoui said, referring to Moderna’s clinical trial.
Monday’s news came as several states prepared to impose strict lockdowns to control an uptick in coronavirus cases as Americans moved more activities indoors for the winter season. Dow Jones Industrial Average futures rose more than 500 points on the news before the opening of markets in New York.
No comments:
Post a Comment